During the past decade, University Hospital Marburg conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Marburg" #1 sponsor was "University of Giessen" with 16 trials, followed by "Actelion" with 2 trials sponsored, "CENTOGENE GmbH Rostock" with 2 trials sponsored, "Carl Zeiss Meditec AG" with 2 trials sponsored and "Philipps University Marburg Medical Center" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Marburg" #1 collaborator was "German Research Foundation" with 2 trials as a collaborator, "Philipps University Marburg Medical Center" with 2 trials as a collaborator, "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Marburg" are "Pulmonary Hypertension" (7 trials), "Heart Failure" (4 trials), "Acute Kidney Injury" (2 trials), "Bladder Cancer" (2 trials) and "Cerebrovascular Accident" (2 trials). Many other conditions were trialed in "University Hospital Marburg" in a lesser frequency.

Most popular intervention types in "University Hospital Marburg" are "Drug" (16 trials), "Other" (9 trials), "Diagnostic Test" (6 trials), "Device" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (7 trials), "Placebo" (3 trials), "bosentan" (2 trials), "AZLI" (1 trials) and "BAROSTIM NEO System" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Marburg" are 45 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Marburg". 1 are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in University Hospital Marburg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Marburg, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".